Jin He Profile
Jin He

@jhatjhmi1

Followers
2K
Following
8K
Media
14
Statuses
1K

Baltimore, MD
Joined November 2015
Don't wanna be here? Send us removal request.
@jhatjhmi1
Jin He
16 days
RT @pashtoonkasi: 🆕🗞️Hot off the press! @NatureMedicine. #KRAS Vaccine💉for patients with RAS➕cancers🎯. Benefit➡️durable.🙌🏽. More to come w….
0
102
0
@jhatjhmi1
Jin He
25 days
RT @Totuccio1983: 6/ Our results support reducing broad-spectrum antibiotic overuse, helping fight antimicrobial resistance while improving….
0
1
0
@grok
Grok
2 days
Join millions who have switched to Grok.
104
188
1K
@jhatjhmi1
Jin He
2 months
RT @ArndtVogel: Nonoperative Management of Mismatch Repair Deficient Tumors.@nejm.🔎Phs-2.👉early dMMR solid tumors a….
0
23
0
@jhatjhmi1
Jin He
2 months
RT @IrcadFrance: #Telesurgery is no longer the future — it’s now. 24 yrs after the Lindbergh Operation, another milestone at #IRCAD: the 1s….
0
7
0
@jhatjhmi1
Jin He
2 months
RT @OncoThor: I am giving a presentation to patients and their families on NETs this weekend. When I was a resident, my oncology attending….
0
5
0
@jhatjhmi1
Jin He
3 months
RT @JHHVascular: Our very own Dr. Bruce Perler @hopkinssurgery receiving the Lifetime Achievement Award at #VAM2025. An inspiration to us a….
0
7
0
@jhatjhmi1
Jin He
3 months
RT @graokane: 🔥NeoPancOne🇨🇦.➡️mFFX in resectable PDAC .➡️exploring GATA6&subtypes .➡️mEFS &OS 16.3 &34.2mths.➡️1yr EFS 90% in GATA6 hi vs 5….
0
45
0
@jhatjhmi1
Jin He
3 months
RT @StefanoCrippa6: 🇮🇹CASSANDRA TRIAL🇮🇹. Phase 3 RCT: Neoadjuvant PAXG vs mFOLFIRINOX in resectable/BR #PDAC . 💥PAXG shows:.✅⬆️EFS.✅⬆️Path….
0
29
0
@jhatjhmi1
Jin He
3 months
RT @juampirocca: This week at NYP/Weill Cornell we completed our 3rd robotic liver transplant, this time using a right lobe living donor gr….
0
9
0
@jhatjhmi1
Jin He
3 months
RT @HalletJulie: Stable OR teams contribute to better outcomes🤝✨. Each additional case done by same anesthesiologist-surgeon team 👉 ⬇️ majo….
0
37
0
@jhatjhmi1
Jin He
4 months
RT @TaigaWaka: 🎸 Robotic PD significantly reduces CR-PF compared to open surgery. Importantly, this clinical advantage was achieved without….
Tweet card summary image
link.springer.com
Surgical Endoscopy - Robotic pancreaticoduodenectomy (RPD) has emerged as a promising surgical approach for the treatment of periampullary neoplasms, offering the potential benefits of minimally...
0
13
0
@jhatjhmi1
Jin He
4 months
RT @MarcBesselink: Does the impact of pancreatic fistula (POPF) differ between minimally invasive (MIPD) and open (OPD) Whipple?. Today in….
0
24
0
@jhatjhmi1
Jin He
4 months
RT @vonderleyen: We will put forward a 500 million package for 2025-2027 to make Europe a magnet for researchers. As well as ambitious p….
0
154
0
@jhatjhmi1
Jin He
4 months
RT @AnnalsofSurgery: The penultimate #AmerSurg25 presentation by @brady_campbell @jhatjhmi1: "Mutational Status of Driver Genes in Patients….
0
5
0
@jhatjhmi1
Jin He
4 months
RT @BoLovvorn: Ronald Weigel, President of ⁦@AmerSurg⁩, delivering provocative perspectives on how to preserve the academic mission of surg….
0
1
0
@jhatjhmi1
Jin He
5 months
RT @SWexner: Purse string suture to decrease circumference but not to close the entire skin defect has been my preference for about 3 decad….
0
27
0
@jhatjhmi1
Jin He
5 months
RT @valentinandreas: 🦠 Microbiome plays a role in pancreatic surgery for PDAC - Enterococcus in bile.→ ⬆️ SSI.→ ⬇️ OS. 🚨 Highest risk: Preo….
0
4
0
@jhatjhmi1
Jin He
5 months
RT @ElliotServaisMD: @SyedAAhmad5 @SurgJournal @SWexner @GregWilson152 I look forward to reading this. 1st impression - congrats to the aut….
0
3
0
@jhatjhmi1
Jin He
5 months
RT @ArndtVogel: 🔥off the press.Liposomal irinotecan for previously treated pts with BTC: A pooled analysis of NIFTY & NALIRICC.@JHepatology….
0
20
0
@jhatjhmi1
Jin He
6 months
RT @alisamae: Another example of robotic surgery decreasing LOS, thus increasing throughput, allowing us to help more patients! Awesome wo….
0
1
0